A Multicenter, Randomized, Double-blind, Placebocontrolled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72- associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

Rowe, Dominic (Primary Chief Investigator)
Gan, Richard (Research Coordinator)
Bayeh, Paula (Research Coordinator)

Project: Research

Short title	WVE-004-001
Status	Not started

Access Project

DRAFT_WAVE WVE-004-001_AU_6109_Rowe_Schedule 2[2]
File: application/msword, 153 KB
Type: Budget
CRG endorsement_ subject to conditions_MQCRG2021039_Rowe
File: application/pdf, 222 KB
Type: Other
Australia_WVE-004-001_23Feb2021
File: application/pdf, 70.1 KB
Type: Other